I-Cetuximab (Erbitux)

-Delile

• Izinkomba
• Isetshenziswa kanjani
• Okuqhamuka uma udla imishanguzo
• Izimo

I-Erbitux iyi-antineoplastic yokusetshenziswa komjovo, esiza ukumisa ukukhula kwamangqamuzana omdlavuza. Lo muthi ungasetshenziswa njengokuyalelwa ngudokotela futhi ungowesibhedlela kuphela.

Imvamisa, lo muthi usetshenziswa emthanjeni ngumhlengikazi kanye ngesonto ukulawula ukukhula komdlavuza.

Izinkomba

Le mithi inconyelwa ukwelashwa komdlavuza wekoloni, umdlavuza we-rectal, umdlavuza wekhanda nomdlavuza wentamo.

Isetshenziswa kanjani

I-Erbitux isetshenziswa ngomjovo emthanjeni ophethwe ngumhlengikazi esibhedlela. Ngokuvamile, ukulawula ukukhula kwesimila, sisetshenziswa kanye ngesonto, ezimweni eziningi umthamo wokuqala ungama-400 mg we-cetuximab nge-m² ngayinye yomzimba womzimba futhi wonke amanani esonto alandelayo angama-250 mg we-cetuximab nge-m² ngayinye.

Ngaphezu kwalokho, ukuqapha ngokucophelela kuyadingeka phakathi nokuphathwa konke komuthi kuze kufike ehoreni elilodwa ngemuva kokufakwa kwesicelo. Ngaphambi kokufakwa, eminye imithi efana nama-antihistamine kanye ne-corticosteroid kufanele inikezwe okungenani ihora elilodwa ngaphambi kokuphathwa kwe-cetuximab.

Okuqhamuka uma udla imishanguzo

Eminye imiphumela emibi yokusebenzisa lo muthi ihlanganisa ukuqunjelwa, ubuhlungu besisu, ukungathandi ukudla, ukuqunjelwa, ukugaya okungalungile, ubunzima bokugwinya, i-mucositis, isicanucanu, ukuvuvukala emlonyeni, ukuhlanza, umlomo owomile, i-anemia, ukwehla kwamaseli amhlophe egazi, ukoma, ukunciphisa umzimba, Ubuhlungu beqolo, i-conjunctivitis, ukulahleka kwezinwele, ukuqubuka kwesikhumba, izinkinga zesipikili, ukulunywa, ukungezwani kwesikhumba ngemisebe, ukukhwehlela, ukuphefumula kanzima, ubuthakathaka, ukudangala, umkhuhlane, ikhanda elibuhlungu, ukuqwasha, ukugodola, ukutheleleka nobuhlungu.

Izimo

Ukusetshenziswa kwalesi sidakamizwa kuyaphikisana nokukhulelwa, ngesikhathi sokuncelisa kanye ne-hypersensitivity kunoma yiziphi izingxenye zomuthi.